Sign In
Buy IGXT
$0.170
+0 (+0%)
At Close: Aug 26, 2025
IntelGenx Launches Preferred Share Regulation A Offering
07:50am, Tuesday, 20'th Feb 2024
SAINT LAURENT, Quebec, Feb. 20, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the launch of a Regulation A offering of up to 2,000,000
IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®
07:15am, Monday, 18'th Dec 2023
SAINT LAURENT, Quebec, Dec. 18, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has entered into development and license agreeme
SAINT LAURENT, Quebec, Dec. 05, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”) announces the closing of the previously announced su
IntelGenx Announces Shareholder Approval of Financing Transactions
04:05pm, Tuesday, 28'th Nov 2023
SAINT LAURENT, Quebec, Nov. 28, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”) is pleased to announce that, at its meeting held ear
IntelGenx Receives Approval to Conduct 'MONTPARK' Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease
07:30am, Tuesday, 14'th Nov 2023
Phase 2 MONTPARK trial expected to begin recruiting patients in Q1 2024 Phase 2 MONTPARK trial expected to begin recruiting patients in Q1 2024
IntelGenx Reminds Shareholders to Vote at Upcoming Special Meeting
08:00am, Monday, 13'th Nov 2023
SAINT LAURENT, Quebec, Nov. 13, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”) wishes to remind its shareholders of record as of Oc
IntelGenx Technologies Corp. (IGXT) Q3 2023 Earnings Call Transcript
08:26pm, Thursday, 09'th Nov 2023
IntelGenx Technologies Corp. (OTCQB:IGXT) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Stephen Kilmer – Investor Relations Dwight Gorham – Chief Executive Offi
IntelGenx Reports Third Quarter 2023 Financial Results
04:05pm, Thursday, 09'th Nov 2023
SAINT LAURENT, Quebec, Nov. 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the third quarter ende
IntelGenx Announces Co-development and Commercialization of Cannabinoid-Infused VersaFilm® Products with Tilray
08:30am, Monday, 06'th Nov 2023
IntelGenx to Manufacture and Supply Three New Filmstrip Products: CBD20, THC10, and THC10:CBD10 IntelGenx to Manufacture and Supply Three New Filmstrip Products: CBD20, THC10, and THC10:CBD10
IntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to Follow
04:45pm, Thursday, 02'nd Nov 2023
SAINT LAURENT, Quebec, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release i
IntelGenx Technologies Corp. (IGXT) Q2 2023 Earnings Call Transcript
11:47pm, Monday, 14'th Aug 2023
IntelGenx Technologies Corp. (OTCQB:IGXT) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Stephen Kilmer - Investor Relations Dwight Gorham - Chief Executive Officer A
IntelGenx to Report Second Quarter 2023 Financial Results on August 14, 2023 – Conference Call to Follow
04:30pm, Monday, 07'th Aug 2023
SAINT LAURENT, Quebec, Aug. 07, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release i
IntelGenx Announces Voting Results on Election of Directors
04:30pm, Thursday, 06'th Jul 2023
SAINT LAURENT, Quebec, July 06, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces that, at the annual meeting of sharehol
IntelGenx Technologies Corp. (IGXT) Q1 2023 Earnings Call Transcript
10:58pm, Thursday, 11'th May 2023
IntelGenx Technologies Corp. (OTCQB:IGXT) Q1 2023 Results Conference Call May 11, 2023 4:30 PM ET Company Participants Stephen Kilmer - Investor Relations Horst Zerbe - Chief Executive Officer Andre G
IntelGenx to Report First Quarter 2023 Financial Results on May 11, 2023 – Conference Call to Follow
04:30pm, Thursday, 04'th May 2023
SAINT LAURENT, Quebec, May 04, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release it
